Can Rhythm Pharmaceuticals (RYTM) ’s New Data Help Patients With a Rare Hunger Disorder?

1 week ago 11

Abdul Rahman

Mon, June 22, 2026 astatine 9:15 AM CDT 2 min read

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) is one of the astir promising healthcare stocks according to Wall Street analysts. On June 13, Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) shared preliminary results from its ongoing Phase 2 proceedings of setmelanotide for Prader-Willi syndrome (PWS) astatine the Endocrine Society's Annual Meeting successful Chicago. The institution said the information showed meaningful improvements successful weight, assemblage composition, hunger, and behavioral outcomes.

Can Rhythm Pharmaceuticals (RYTM) 's New Data Help Patients With a Rare Hunger Disorder?

sunabesyou/Shutterstock.com

For context, PWS is simply a uncommon familial upset that causes a near-constant, overwhelming consciousness of hunger starting successful aboriginal childhood. The information leads to terrible obesity and important behavioral and affectional challenges. Currently, determination are precise fewer treatments that tin meaningfully code this condition.

According to the data, patients connected mean saw their BMI driblet by conscionable implicit 3% astatine the six-month mark. The reductions were accordant crossed some adults and children. Also, setmelanotide showed meaningful improvements successful the excessive hunger that defines PWS, that is, 8 retired of 10 patients who entered the proceedings with mean to terrible hyperphagia saw their hunger scores amended significantly.

Rhythm added that the information illustration of setmelanotide successful this proceedings was accordant with what has already been established successful anterior studies. The institution said these results springiness it the assurance to determination guardant into a Phase 3 proceedings for PWS. This signifier volition beryllium a larger, much rigorous study.

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) is simply a commercial-stage biopharmaceutical company. It is focused connected processing and commercializing therapies for uncommon familial diseases of obesity.

While we admit the imaginable of RYTM arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 12 High-Growth Micro-Cap Stocks to Buy Now and 10 Best Long-Term Stocks to Invest In According to Bill & Melinda Gates Foundation Trust.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article